查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1977778

2026-2034年全球獸醫整形外科市場規模、佔有率、趨勢和成長分析報告

Global Veterinary Orthopedic Medicine Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計獸醫整形外科醫療市場將從 2025 年的 24.6 億美元成長到 2034 年的 52.9 億美元，2026 年至 2034 年的複合年成長率為 8.87%。

意識提升，全球獸醫整形外科市場正穩步成長。寵物骨折、韌帶損傷和關節疾病發生率的上升，刺激了對整形外科治療的需求。飼主越來越願意為寵物提供先進的獸醫護理，包括手術和再生醫學，這促進了已開發國家和新興市場的發展。

關鍵成長要素包括獸醫外科技術的進步、診斷影像技術的改進以及創新植入和生物製藥的廣泛應用。寵物保險費率的上漲和獸醫醫院網路的擴張也促進了治療的可及性。此外，畜牧管理標準的提高也增加了對畜牧整形外科解決方案的需求。

展望未來，包括幹細胞療法和3D列印植入在內的再生醫學可望推動市場發展。技術創新和微創手術有望改善患者的復原效果。寵物人性化趨勢的日益成長以及亞太和拉丁美洲獸醫基礎設施的擴張將進一步推動市場長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球獸用整形外科市場：依產品分類

  • 市場分析、洞察與預測
  • 生物製藥
  • 黏性補充
  • 製藥

第5章：全球獸用整形外科市場：依動物類型分類

  • 市場分析、洞察與預測
  • 狗
  • 馬
  • 其他

第6章：全球獸醫整形外科市場：依應用領域分類

  • 市場分析、洞察與預測
  • 骨關節炎
  • 退化性關節疾病
  • 其他用途

第7章：全球獸用整形外科市場：依給藥途徑分類

  • 市場分析、洞察與預測
  • 口服
  • 注射藥物
  • 其他

第8章：全球獸用整形外科市場：依最終用途分類

  • 市場分析、洞察與預測
  • 動物醫院
  • 動物診所
  • 其他

第9章：全球獸醫整形外科市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Zoetis
    • Boehringer Ingelheim
    • Elanco Animal Health
    • American Regent
    • Merck Animal Health
    • Vetoquinol
    • Ceva Sante Animale
    • Virbac
    • Biogenesis Bago
    • Ardent Animal Health
    • Bioiberica
    • PetVivo Holdings
    • Contipro
簡介目錄
Product Code: VMR112113276

The Veterinary Orthopedic Medicine Market size is expected to reach USD 5.29 Billion in 2034 from USD 2.46 Billion (2025) growing at a CAGR of 8.87% during 2026-2034.

The global veterinary orthopedic medicine market is experiencing steady growth due to the rising adoption of companion animals and increasing awareness about animal health. Growing cases of fractures, ligament injuries, and joint disorders in pets are driving demand for orthopedic treatments. Pet owners are increasingly willing to spend on advanced veterinary care, including surgical procedures and regenerative therapies, which supports market expansion across developed and emerging economies.

Key growth drivers include advancements in veterinary surgical techniques, improved diagnostic imaging, and the availability of innovative implants and biologics. The rise in pet insurance coverage and expanding veterinary hospital networks are also strengthening treatment access. In addition, increasing livestock management standards are contributing to demand for orthopedic solutions in farm animals.

Looking ahead, the market is expected to benefit from regenerative medicine, including stem cell therapy and 3D-printed implants. Technological innovations and minimally invasive surgical procedures will likely enhance recovery outcomes. Growing pet humanization trends and expanding veterinary infrastructure in Asia-Pacific and Latin America will further drive long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Biologics
  • Visco supplements
  • Pharmaceuticals

By Animal Type

  • Canine
  • Equine
  • Others

By Application

  • Osteoarthritis
  • Degenerative Joint Disease
  • Other Applications

By Route of Administration

  • Oral
  • Injectable
  • Others

By End Use

  • Veterinary Hospitals
  • Veterinary Clinics
  • Others

COMPANIES PROFILED

  • Zoetis, Boehringer Ingelheim, Elanco Animal Health, American Regent, Merck Animal Health, Vetoquinol, Ceva Sante Animale, Virbac, Biogenesis Bago, Ardent Animal Health, Bioiberica, PetVivo Holdings, Contipro
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Biologics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Visco supplements Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Pharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Animal Type
  • 5.2. Canine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Equine Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Osteoarthritis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Degenerative Joint Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Route Of Administration
  • 7.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET: BY END USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End Use
  • 8.2. Veterinary Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Veterinary Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL VETERINARY ORTHOPEDIC MEDICINE MARKET: BY REGION 2022-2034(USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Product
    • 9.2.2 By Animal Type
    • 9.2.3 By Application
    • 9.2.4 By Route Of Administration
    • 9.2.5 By End Use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Product
    • 9.3.2 By Animal Type
    • 9.3.3 By Application
    • 9.3.4 By Route Of Administration
    • 9.3.5 By End Use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Product
    • 9.4.2 By Animal Type
    • 9.4.3 By Application
    • 9.4.4 By Route Of Administration
    • 9.4.5 By End Use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Product
    • 9.5.2 By Animal Type
    • 9.5.3 By Application
    • 9.5.4 By Route Of Administration
    • 9.5.5 By End Use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 South East Asia
    • 9.5.11 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Product
    • 9.6.2 By Animal Type
    • 9.6.3 By Application
    • 9.6.4 By Route Of Administration
    • 9.6.5 By End Use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL VETERINARY ORTHOPEDIC MEDICINE INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Zoetis
    • 11.2.2 Boehringer Ingelheim
    • 11.2.3 Elanco Animal Health
    • 11.2.4 American Regent
    • 11.2.5 Merck Animal Health
    • 11.2.6 Vetoquinol
    • 11.2.7 Ceva Sante Animale
    • 11.2.8 Virbac
    • 11.2.9 Biogenesis Bago
    • 11.2.10 Ardent Animal Health
    • 11.2.11 Bioiberica
    • 11.2.12 PetVivo Holdings
    • 11.2.13 Contipro